Sino Biopharmaceutical | 1177 - Ordinary Share Capital


Sino Biopharmaceutical reported CNY17.89B in Ordinary Share Capital for its fiscal semester ending in June of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Jiangsu Hengrui CNY 6.64B 0 Dec/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Revvity USD 113.38M 2.7M Dec/2025
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025